Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2007 1
2008 4
2009 3
2010 7
2011 12
2012 13
2013 13
2014 12
2015 17
2016 13
2017 20
2018 38
2019 37
2020 56
2021 37
2022 31
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 28941078

260 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of mechanical circulatory support with Impella or intra-aortic balloon pump for high-risk percutaneous coronary intervention and/or cardiogenic shock: Insights from a network meta-analysis of randomized trials.
Kuno T, Takagi H, Ando T, Kodaira M, Numasawa Y, Fox J, Bangalore S. Kuno T, et al. Catheter Cardiovasc Interv. 2021 Apr 1;97(5):E636-E645. doi: 10.1002/ccd.29236. Epub 2020 Sep 7. Catheter Cardiovasc Interv. 2021. PMID: 32894797
Utilization of the Impella for hemodynamic support during percutaneous intervention and cardiogenic shock: an insight.
Nalluri N, Patel N, Saouma S, Anugu VR, Anugula D, Asti D, Mehta V, Kumar V, Atti V, Edla S, Grewal RK, Khan HM, Kanotra R, Maniatis G, Kandov R, Lafferty JC, Dyal M, Alfonso CE, Cohen MG. Nalluri N, et al. Expert Rev Med Devices. 2017 Oct;14(10):789-804. doi: 10.1080/17434440.2017.1374849. Epub 2017 Sep 11. Expert Rev Med Devices. 2017. PMID: 28862481 Review.
Impact of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing high-risk percutaneous coronary intervention (from the PROTECT II randomized trial).
Dangas GD, Kini AS, Sharma SK, Henriques JP, Claessen BE, Dixon SR, Massaro JM, Palacios I, Popma JJ, Ohman M, Stone GW, O'Neill WW. Dangas GD, et al. Am J Cardiol. 2014 Jan 15;113(2):222-8. doi: 10.1016/j.amjcard.2013.09.008. Am J Cardiol. 2014. PMID: 24527505 Clinical Trial.
260 results